Autopsy report · NCT00161200

Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor

“slow accrual”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 9 months after it had already started.
• Ran for about 3 years 10 months before it stopped.
• 60 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University of Medicine and Dentistry of New Jersey

Sponsor type

University, hospital or other

Conditions

Esophageal Metaplasia

Interventions

Ranitidine & Pantoprazole

Participants

60

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.